Osteoporosis and Osteopathy Markers in Patients with Mastocytosis
Tarih
2015Yazar
Sindel, Dilsad
Buyukbabani, Nesimi
Kanitez, Nilufer Alpay
Tanakol, Refik
Erer, Burak
Yayuz, Akif Selim
Dogan, Oner
Baykal, Can
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: Osteoporosis, osteosclerosis, and lytic bone lesions have been observed in patients with systemic mastocytosis (SM). We examined bone mineral density (BMD) biochemical turnover markers and serum tryptase levels in SM, which is considered a rare disease.
Koleksiyonlar
- Makale [92796]